What sector is JBIO in?

Jade Biosciences, Inc. Common Stock (JBIO) operates in the Healthcare sector, specifically in the PHARMACEUTICAL PREPARATIONS industry.

What is JBIO's market cap?

Jade Biosciences, Inc. Common Stock (JBIO) has a market capitalization of $1.30B.

How can I analyze JBIO stock?

Valhalla provides comprehensive analysis for JBIO including institutional trade flow, dark pool activity, options data, technical indicators, and proprietary scoring. Visit valhalla-labs.io/stocks/JBIO for a full breakdown.

Where can I find institutional trades for JBIO?

Valhalla tracks real-time institutional trade flow for JBIO, including dark pool blocks, lit block trades, and sweep orders. These insights help identify where smart money is positioned.

JBIO

Q: What is JBIO (Jade Biosciences, Inc. Common Stock)?

Jade Biosciences, Inc. Common Stock (JBIO) is a healthcare company in the pharmaceutical preparations industry. Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A P

Jade Biosciences, Inc. Common Stock

Healthcare — PHARMACEUTICAL PREPARATIONS

Valhalla Score 68

$24.11

Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for the treatment of immunoglobulin A (IgA) nephropathy. JADE-001 is anticipated to enter clinical trials in the second half of 2025, with initial data expected in the first half of 2026. The company's pipeline also includes two preclinical antibody programs, JADE-002 and JADE-003.

Latest Healthcare Sector News

ROSEN, A LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCNew York, New York--(Newsfile Corp. - May 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscie...newsfilecorp.com — May 1, 2026

JBIO Data Insights

Dark pool activity detected in the last 5 trading days

Subscribe for full dark pool analysis, institutional flow, and real-time alerts.

📊 Key Statistics

Market Cap$1.30B

P/E Ratio—

EPS (TTM)—

EPS YoY—

Revenue YoY—

Float—

Short Float %—

Inst. Ownership—

Sector RS—

📈 Fundamentals

ROE—

ROIC—

ROA—

Current Ratio—

Debt/Equity—

Gross Margin—

Net Margin—

Dividend Yield—

Next Earnings—

⚡ Options Summary

Call OI—

Put OI—

P/C Ratio (OI)—

Gamma Environment—

Max Pain—

Call Wall—

Put Wall—

🎯 Analyst Estimates

Consensus Target—

High Target—

Low Target—

Analysts—

Upside/Downside—

📋 Quarterly Financials

Period	Revenue	Rev YoY	EPS	EPS YoY	Gross Margin

Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

Type	Strike	Exp	Size	Premium	Time

Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

Type	Price	Size	Value	Venue	Time

Start Free Trial Full insider & congressional trade history

👤 Insider Trades

Name	Type	Shares	Price	Date

Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

Institution	Shares	Value	% of Class